20291-99-0Relevant articles and documents
HETEROCYCLIC COMPOUNDS AS INHIBITORS OF KRAS G12C
-
Page/Page column 103, (2021/01/23)
Provided are heterocyclic compounds as inhibitors of the KRAS G12C and uses thereof. Specifically, provided are the compounds of any of formula I to XI or stereoisomers, enantiomers, atropoisomerics or pharmaceutically acceptable salts thereof. Definition of each group in the formula can be found in the specification for details.
Novel sirtuin inhibitory warheads derived from the Nε-acetyl-lysine analog l-2-amino-7-carboxamidoheptanoic acid
He, Yanhua,Yan, Lingling,Zang, Wenwen,Zheng, Weiping
supporting information, p. 10442 - 10450 (2015/11/10)
Built upon the catalytic mechanism-based pan-SIRT1/2/3 inhibitory warhead l-2-amino-7-carboxamidoheptanoic acid (l-ACAH, a close structural analog of Nε-acetyl-lysine) that our laboratory discovered recently, in the current study, its carboxami
Evaluation of small-molecule modulators of the luteinizing hormone/choriogonadotropin and thyroid stimulating hormone receptors: Structure-activity relationships and selective binding patterns
Moore, Susanna,Jaeschke, Holger,Kleinau, Gunnar,Neumann, Susanne,Costanzi, Stefano,Jiang, Jian-Kang,Childress, John,Raaka, Bruce M.,Colson, Anny,Paschke, Ralf,Krause, Gerd,Thomas, Craig J.,Gershengorn, Marvin C.
, p. 3888 - 3896 (2007/10/03)
The substituted thieno[2,3-d]pyrimidine 3 (Org 41841), a partial agonist for the luteinizing hormone/choriogonadotropin receptor (LHCGR) and the closely related thyroid-stimulating hormone receptor (TSHR), was fundamentally altered, and the resulting anal